Orchestra BioMed Holdings (OBIO) Gross Profit (2022 - 2026)
Orchestra BioMed Holdings (OBIO) reported Gross Profit of $78000.0 for Q1 2026, down 90.53% year-over-year from $824000.0 in Q1 2025, and down 99.75% on a QoQ basis from $30.9 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) has 5 years of Gross Profit data on file, last reported at $78000.0 in Q1 2026.
- Quarterly Gross Profit fell 90.53% year-over-year to $78000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.5 million (up 1118.04% YoY) and the FY2025 annual result came in at $33.3 million, up 1267.79% from the prior year.
- Gross Profit eased to $78000.0 in Q1 2026 per OBIO's latest filing, from $30.9 million in the prior quarter.
- Across five years, Gross Profit topped out at $30.9 million in Q4 2025 and bottomed at $78000.0 in Q1 2026.
- The 5-year median for Gross Profit is $812000.0 (2025), against an average of $2.5 million.
- The widest annual swing landed in 2025, when Gross Profit jumped 15728.72%; it then slumped 90.53% in 2026.
- Tracing OBIO's Gross Profit over 5 years: stood at $1.0 million in 2022, then tumbled by 79.52% to $215000.0 in 2023, then dropped by 9.3% to $195000.0 in 2024, then jumped by 15728.72% to $30.9 million in 2025, then sank by 99.75% to $78000.0 in 2026.
- Per Business Quant, the three latest OBIO Gross Profit figures stand at $78000.0 (Q1 2026), $30.9 million (Q4 2025), and $812000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Orchestra BioMed Holdings | 245.24 Mn | 255.02 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 30.87 Mn |
| Dec 31, 2025 | 30.87 Mn |
| Sep 30, 2025 | 812,000.00 |
| Sep 30, 2025 | 812,000.00 |
| Jun 30, 2025 | 790,000.00 |
| Jun 30, 2025 | 790,000.00 |
| Mar 31, 2025 | 824,000.00 |
| Mar 31, 2025 | 824,000.00 |
| Dec 31, 2024 | 195,000.00 |
| Dec 31, 2024 | 195,000.00 |
| Sep 30, 2024 | 919,000.00 |
| Sep 30, 2024 | 919,000.00 |
| Jun 30, 2024 | 734,000.00 |
| Jun 30, 2024 | 734,000.00 |
| Mar 31, 2024 | 586,000.00 |
| Mar 31, 2024 | 586,000.00 |
| Dec 31, 2023 | 215,000.00 |
| Dec 31, 2023 | 215,000.00 |
| Sep 30, 2023 | 378,000.00 |
| Sep 30, 2023 | 378,000.00 |
| Jun 30, 2023 | 861,000.00 |
| Jun 30, 2023 | 861,000.00 |
| Mar 31, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 341,000.00 |
| Jun 30, 2022 | 341,000.00 |
| Mar 31, 2022 | 824,000.00 |
| Mar 31, 2022 | 824,000.00 |